Interpersonal Relationships Intervention and Cardiovascular Health
An Interpersonal Relationships Intervention for Improving Cardiovascular Health in Youth
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Edith Chen
- Phone Number: 8474670366
- Email: edith.chen@northwestern.edu
Study Locations
-
-
Illinois
-
Evanston, Illinois, United States, 60208
- Northwestern
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- undergraduate students for mentors
- Chicago Public School students for mentees
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Intervention (Mentor/Mentee)
Youth in the intervention group will participate in one-on-one mentoring sessions (between mentors and mentees) once per week after school.
Mentoring sessions will focus on social relationships, coping behaviors, and healthy lifestyles.
|
The intervention will include one-on-one mentoring sessions held after school, focusing on coping, social relationships, and healthy lifestyles.
|
|
Active Comparator: Comparison group - written materials
Youth in the comparator group will receive written versions of all materials covered in the mentoring sessions.
|
Written materials from the mentoring sessions will be provided to those in the comparison group
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Metabolic symptoms
Time Frame: Change in metabolic symptoms from baseline to approximately 1 year later
|
Metabolic symptoms per International Diabetes Federation guidelines
|
Change in metabolic symptoms from baseline to approximately 1 year later
|
|
Flow-mediated vasodilation
Time Frame: Change in flow-mediated vasodilation from baseline to approximately 1 year later
|
Brachial artery diameter change
|
Change in flow-mediated vasodilation from baseline to approximately 1 year later
|
|
HOMA-IR
Time Frame: Change in HOMA-IR score from baseline to approximately 1 year later
|
Homeostatic Model Assessment of Insulin Resistance
|
Change in HOMA-IR score from baseline to approximately 1 year later
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pro-inflammatory cytokines
Time Frame: Change from baseline to approximately 1 year later
|
Standardized and averaged values of pro-inflammatory cytokines + CRP
|
Change from baseline to approximately 1 year later
|
|
Stimulated cytokine production
Time Frame: Change from baseline to approximately 1 year later
|
Standardized and averaged values of stimulated pro-inflammatory cytokines
|
Change from baseline to approximately 1 year later
|
|
Glucocorticoid sensitivity
Time Frame: Change from baseline to approximately 1 year later
|
Standardized and averaged values of cytokine production after stimulation plus addition of cortisol
|
Change from baseline to approximately 1 year later
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- 00203223
- R01HL136676 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.